Publications (53) Publications in which a researcher has participated

2004

  1. Agonist-Specific Coupling of Growth Hormone Secretagogue Receptor Type 1a to Different Intracellular Signaling Systems: Role of Adenosine

    Neuroendocrinology, Vol. 79, Núm. 1, pp. 13-25

  2. Alteraciones neuroendocrinas en la obesidad.

    Revista de medicina, Vol. 48, Núm. 2, pp. 24-29

  3. Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: A cross-sectional study using the minimal model

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 11, pp. 1462-1466

  4. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions

    Neurochemistry International, Vol. 45, Núm. 1, pp. 103-116

  5. Boxing as a sport activity associated with isolated GH deficiency

    Journal of Endocrinological Investigation, Vol. 27, Núm. 11

  6. CD4-CD8 and CD28 Expression in T Cells Infiltrating the Vitreous Fluid in Patients with Proliferative Diabetic Retinopathy: A Flow Cytometric Analysis

    Archives of Ophthalmology, Vol. 122, Núm. 5, pp. 743-749

  7. Características demográficas y clínicas de 69 pacientes con hipopituitarismo diagnosticado en la edad adulta

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 51, Núm. 6, pp. 351-358

  8. Circulating and cerebrospinal fluid ghrelin and leptin: Potential role in altered body weight in Huntington's disease

    European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 451-455

  9. Complicaciones crónicas de la diabetes mellitus

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 16, pp. 990-999

  10. Desensitization and Endocytosis Mechanisms of Ghrelin-Activated Growth Hormone Secretagogue Receptor 1a

    Endocrinology, Vol. 145, Núm. 2, pp. 930-940

  11. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)

    European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446

  12. Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adults

    Clinical Endocrinology, Vol. 60, Núm. 2, pp. 185-191

  13. Expression of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in Normal Human Testis and Testicular Tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 89, Núm. 1, pp. 400-409

  14. Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa

    Journal of Endocrinological Investigation, Vol. 27, Núm. 6, pp. 523-527

  15. Growth hormone (GH) peaks versus areas under the curve in the diagnosis of adult GH deficiency: Analysis of the variables provided by the GHRH + GHRP-6 test

    Pituitary, Vol. 7, Núm. 1, pp. 15-20

  16. Growth hormone response to GHRH + GHRP-6 in type 2 diabetes during euglycemic and hyperglycemic clamp

    Diabetes Research and Clinical Practice, Vol. 63, Núm. 1, pp. 37-45

  17. Grupo de nutrición de la SEEN

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 51, Núm. 1, pp. 14-18

  18. High leptin levels in women developing postpartum thyroiditis

    Clinical Endocrinology, Vol. 60, Núm. 2, pp. 208-213

  19. Hipercalcemia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 17, pp. 1055-1062

  20. Hipocalcemia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 17, pp. 1045-1054